Loading company
Loading
Latest annual · FY2025
Millions- Total revenues
- 4
- Gross profit
- 2
- Operating income
- (13)
- Net income
- (13)
- Free cash flow
- (11)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +78.7%
Tenon Medical, Inc. (TNON) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $3.9 million | $3.3 million | +20.4% | 10-K 2026-03-27 · proof |
| Gross profit | $2.4 million | $1.7 million | +37.8% | 10-K 2026-03-27 · proof |
| Operating income | -$12.8 million | -$13.8 million | 10-K 2026-03-27 · proof | |
| Net income | -$12.6 million | -$13.7 million | 10-K 2026-03-27 · proof | |
| Cash from operating activities | -$10.7 million | -$9.9 million | 10-K 2026-03-27 · proof | |
| Free cash flow | -$11 million | -$10.1 million | 10-K 2026-03-27 · proof | |
| Total assets | $10.8 million | $9.8 million | +9.3% | 10-K 2026-03-27 · proof |
| Total liabilities | $5.7 million | $3.9 million | +47.7% | 10-K 2026-03-27 · proof |
| Cash and cash equivalents | $3.8 million | $6.5 million | -42.5% | 10-K 2026-03-27 · proof |
- What was Tenon Medical, Inc. (TNON)'s revenue in fiscal 2025?
- Tenon Medical, Inc. (TNON) reported revenue of $3.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $3.3 million the year before (+20.4%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Tenon Medical, Inc. (TNON)'s gross profit in fiscal 2025?
- Tenon Medical, Inc. (TNON) reported gross profit of $2.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $1.7 million the year before (+37.8%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Tenon Medical, Inc. (TNON)'s operating income in fiscal 2025?
- Tenon Medical, Inc. (TNON) reported operating income of -$12.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$13.8 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Tenon Medical, Inc. (TNON)'s net income in fiscal 2025?
- Tenon Medical, Inc. (TNON) reported net income of -$12.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$13.7 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Tenon Medical, Inc. (TNON)'s cash from operating activities in fiscal 2025?
- Tenon Medical, Inc. (TNON) reported cash from operating activities of -$10.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$9.9 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Tenon Medical, Inc. (TNON)'s free cash flow in fiscal 2025?
- Tenon Medical, Inc. (TNON) reported free cash flow of -$11 million for fiscal 2025 (the year ended Dec 31, 2025), against -$10.1 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What are Tenon Medical, Inc. (TNON)'s total assets?
- As of Dec 31, 2025, Tenon Medical, Inc. (TNON) reported total assets of $10.8 million, against $9.8 million a year earlier (+9.3%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What are Tenon Medical, Inc. (TNON)'s total liabilities?
- As of Dec 31, 2025, Tenon Medical, Inc. (TNON) reported total liabilities of $5.7 million, against $3.9 million a year earlier (+47.7%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What are Tenon Medical, Inc. (TNON)'s cash and cash equivalents?
- As of Dec 31, 2025, Tenon Medical, Inc. (TNON) reported cash and cash equivalents of $3.8 million, against $6.5 million a year earlier (-42.5%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:TNON&period_type=annual&limit=5"Information only, not investment advice.